The global Leukapheresis Market was valued at USD 62 million in 2022 and it is anticipated to grow further till USD 136 million by 2032, at a CAGR of 8.2% during the forecast period.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10318
The method of leukapheresis is used to remove white blood cells from a blood sample. It is done to lower the number of elevated white blood cells, to gain cells for different types of research, and to collect autologous blood cells for transplanting back into the patient.
Leukapheresis is a form of apheresis that removes a component of blood and then reincorporates the remaining blood into circulation. White blood cells are isolated during chemotherapy in order to protect them from potential harm from the high dosage of chemotherapy medications. They are then returned to the patient’s body.
Get A Customized Scope to Match, Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10318
Market Trends and Drivers
Leukemia incidence has drastically increased across the globe. The American Cancer Society predicts that there will be 61,090 new cases of leukemia in the US in 2021. In addition, it is predicted that leukemia would be responsible for 23,660 fatalities in the US in 2021. Between 2008 and 2020, the incidence rate of leukemia in children increased by 1% year. It is logical to assume that the increased prevalence of hyper leukocytic leukemia will increase the need for therapeutic leukapheresis operations in the next years and support the expansion of the leukapheresis market.
Despite its therapeutic benefits, leukapheresis is still not widely used as a treatment, especially for hyper leukocytic leukemia. But industry participants are starting to pay more attention to how therapeutic leukapheresis is used to treat pediatric patients. The risks and side effects of conventional treatments, such as chemotherapy for children, can be primarily blamed for this. Children’s stem cells can be obtained through leukapheresis and utilized to treat or remove extra WBCs in patients with juvenile lymphoma or other cancers. Given that so few hospitals now offer leukapheresis treatment for children in both established and emerging economies, leukapheresis is an area of focus in this market due to the potential and benefits it offers in this application.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/checkout/single_user/GIS10318
Global Leukapheresis Market Segmentation
By Type
- Leukapheresis Devices
- Apheresis Devices
- Leukoreduction Filters
- Leukapheresis Columns & Cell Separators
By Application
- Research Applications
- Therapeutic Applications
By End Users
- Blood Component Providers & Blood Centers
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Transfusion Centers
Major Players in the Global Leukapheresis Market
The key players studied in the report are Fresenius, Asahi Kasei Medical, Haemonetics, STEMCELL Technologies, Terumo BCT, Macopharma, HemaCare, Caltag Medsystem, StemExpress, Key Biologics LLC, ZenBio Inc, Digital Pharmacist Inc, BioIVT, Precision for Medicine Inc, and Lmb Technologie GmbH among others.
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/